SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-004345
Filing Date
2023-02-03
Accepted
2023-02-03 08:30:28
Documents
13
Period of Report
2023-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc10047533_8k.htm   iXBRL 8-K 36640
  Complete submission text file 0001140361-23-004345.txt   215649

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bngo-20230202.xsd EX-101.SCH 4327
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20230202_def.xml EX-101.DEF 17538
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20230202_lab.xml EX-101.LAB 27036
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20230202_pre.xml EX-101.PRE 19723
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10047533_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 23583812
SIC: 3826 Laboratory Analytical Instruments